SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Park Meditech PMDTF

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ed Mitukiewicz who wrote (7)6/2/1996 12:35:00 AM
From: Sylvain Cousineau   of 216
 
Here's a news release about that convention in New York

HEALTHCARE FIRMS CONVERGE ON BIG APPLE; CRUTTENDEN ROTH EVENT TARGETS WALL
STREET
PR Newswire, May 13, 1996 09:19 (4K)
Wire Services

HEALTHCARE FIRMS CONVERGE ON BIG APPLE; CRUTTENDEN ROTH EVENT TARGETS WALL
STREET

IRVINE, Calif., May 13 /PRNewswire/ -- Go east, young companies, go east! In
the first conference of its kind, West Coast-based underwriter Cruttenden
Roth will lead a delegation of 35 companies to meet with Wall Street
investors in June.

Heads of some of California's fastest-growing biomed, medical device and
healthcare companies, will be converging on the Big Apple hoping to catch
the eyes and wallets of the nation's institutional investors.

Top management from 35, mostly western companies, will be showcasing their
products at the Cruttenden Roth Healthcare Growth Stock Conference,
scheduled for June 6 from 8 AM to 5:30 PM at the St. Regis Hotel in New
York. Cruttenden Roth is one of the top performing underwriters in the
nation and specializes in emerging growth companies.

This is the first year Cruttenden Roth is devoting a conference exclusively
to healthcare, according to Byron Roth, Cruttenden Roth president. "Few
investment companies focus on this `small cap' segment of the market. Our
conference provides a unique forum where these emerging growth companies can
meet one-on-one with some of the most influential investors and analysts on
Wall Street," continued Roth.

During the one-day event, each company will present to an audience of over
200 institutional investors and stock analysts. Presentations will be
followed by breakout sessions where investors will get face- time with each
company's management, and receive hands-on demonstrations of the company's
new products.

This formula has proved successful at Cruttenden Roth's other conferences;
also tailored for smaller public companies. Each year, the underwriter holds
Growth Stock Conferences in California. Because of their unique focus, the
events have become nationally recognized media events. The most recent
conference, held in Laguna Niguel, California in February, drew a record
attendance of 1,000 people from throughout the U.S. and Europe, including
100 companies.

Co-sponsors of this year's event includes Stradling Yocca Carlson & Rauth, a
West Coast based law firm, and PR Newswire.

Audience attendance is limited to institutional investors, financial
advisors, analysts and portfolio managers. For more information call Sue
Sherry at Cruttenden Roth: (714) 757-5786.

Cruttenden Roth is a regional investment bank and brokerage specializing in
emerging growth companies. Headquartered in Irvine, California, the company
maintains regional offices in La Jolla, Los Angeles, Santa Barbara, Menlo
Park, San Francisco, California; Seattle, Washington, and Denver, Colorado.
It is a member of the National Association of Securities Dealers, Inc.
(NASD), the Securities Industry Association (SIA), and the Securities
Investor Protection Corporation. (SIPC).

A partial list of presenting companies:

Accumed International, Inc. (ACMI)

Advanced Tissue Sciences, Inc. (ATIS)

Alliance Pharmaceutical Corp. (ALLP)

Applied Microbiology, Inc. (AMBI)

Atrix Laboratories, Inc. (ATRX)

BioLase Technology, Inc. (BLTI)

BioSource International, Inc. (BIOI)

DUSA Pharmaceuticals, Inc. (DUSA)

Empyrean Diagnostics, Ltd. (EMD)

Endocare, Inc. (ENDO)

HemaSure Inc. (HMSR)

I.S.G. Technologies, Inc. (ISGTF)

Imatron Inc. (IMAT)

InnerDyne, Inc. (IDYN)

Interpore International (BONZ)

LifeCell Corporation (LIFC)

Medical Asset Management (MAMT)

MiniMed, Inc. (MNMD)

Neoprobe Corporation (NEOP)

Palomar Medical Technologies, Inc. (PMTI)

Park Meditech, Inc. (PMDTF)

PHAMIS, Inc. (PHAM)

PLC Medical Systems (PLC)

PolyMedica Industries, Inc. (PM)

Protein Polymer Technologies, Inc. (PPTI)

Quality Systems, Inc. (QSII)

Rockford Industries, Inc. (ROCF)

Safeguard Health Enterprises, Inc. (SFGD)

Thoratec Laboratories Corporation (TLC)

Unimed Pharmaceuticals, Inc. (UMED)

Unison Healthcare Corporation (UNHC)

Utah Medical Products, Inc. (UTMD)

VOXEL (VOXL)

Zonagen, Inc. (ZONA)

/CONTACT: Nevena Orbach of the Orbach Co., 818-904-0500; or H.D. Thoreau of
Cruttenden Roth, 415-854-5526, 714-757-5786/

CO: Cruttenden Roth ST: California IN: HEA FIN SU:

TT-SS 0136 05/13/96 09:05 EDT

Copyright 1996, PR Newswire

This article is copyrighted. Any unauthorized access, reproduction or
distribution is strictly prohibited.
----------------------------------------------------------------------------

HELP HOME QUERY ACCOUNT INFO FEEDBACK TITLES
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext